Skip to main content
    D

    Diversified Healthcare Trust (DHC)

    Official site

    REAL ESTATE • REIT - HEALTHCARE FACILITIES • NASDAQ

    $7.16
    +0.06 (+0.85%)

    Market Cap: $1.72B

    Last updated: Nov 17, 2026 at 4:33 PM ET

    Diversified Healthcare Trust (DHC) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Diversified Healthcare Trust (DHC) has a market cap of $1.72B and a P/FFO of 10.4x on its 2026 FFO estimate. Its net debt of $2.29B equals 133.19% of its market cap. It kept -10.29% of revenue as net income over the last 12 months.

    Total Valuation

    Enterprise value is 133.19% above the market cap, as debt exceeds cash.

    Market Cap$1.72B
    Enterprise Value$4.02B
    Latest price (Nov 17, 2026)$7.16

    Key Dates

    The next earnings report is expected on Feb 22, 2027, covering the quarter ending Dec 31, 2026. The last ex-dividend date was Oct 19, 2026.

    Next Earnings DateFeb 22, 2027 (expected)
    Last Earnings DateNov 2, 2026
    Last Ex-Dividend DateOct 19, 2026
    Last Payment DateNov 12, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.10% in the quarter ended Sep 30, 2026 and grew 0.27% a year over 2 years.

    Shares Outstanding240.98M
    Other Share ClassesDHCNL
    Shares Change (YoY)+0.25%
    Shares Change (QoQ)+0.10%
    Share Count Growth (2Y CAGR)+0.27%

    Valuation Ratios

    P/FFO is 10.4x on the 2026 FFO estimate of $0.69 a share. Its year-end P/S ranged from 0.1x to 4.2x from 2016 to 2025.

    P/FFO (2026 estimate)10.4x
    P/S Ratio1.2x
    Forward P/S1.2x
    P/B Ratio1.1x
    P/TBV Ratio1.1x
    P/OCF Ratio31.9x

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 16.3x EBITDA.

    EV / Sales2.7x
    EV / EBITDA16.3x

    Price Statistics

    The stock is up 54.92% over 52 weeks and trades 6.41% below its 50-day average.

    Beta (1Y)0.64
    52-Week Change+54.92%
    1-Month Change-2.85%
    3-Month Change-11.48%
    6-Month Change-16.46%
    5-Year Change+113.74%
    10-Year Change-63.42%
    Total Return (1Y)+55.78%
    Total Return (3Y CAGR)+51.28%
    Total Return (5Y CAGR)+18.80%
    Return vs SPY (1Y)+45.05%
    Max Drawdown (1Y)-27.08%
    Max Drawdown (3Y)-51.17%
    Sharpe Ratio (1Y)1.20
    Correlation with SPY (1Y)0.24
    50-Day Average$7.65
    200-Day Average$7.85
    52-Week Range$4.32 to $9.65
    RSI (14 Days)39.2
    Average Volume (20 Days)1.81M

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 400.45x current liabilities, and total debt is 1.57x shareholder equity.

    Current Ratio400.45x
    Quick Ratio400.45x
    Debt / Equity1.57x
    Debt / EBITDA9.76x
    Interest Coverage-0.14x

    Returns and Efficiency

    Return on invested capital is -0.58% over the last 12 months, against a 5-year average of 0.78%.

    Return on Equity (ROE)-9.94%
    Return on Assets (ROA)-3.63%
    Return on Invested Capital (ROIC)-0.58%
    Return on Capital Employed (ROCE)-0.55%
    ROE (5Y Average)-8.49%
    ROA (5Y Average)-3.34%
    ROIC (5Y Average)0.78%
    Asset Turnover0.33x

    Scores

    DHC has a Piotroski F-Score of 5 of 9, in the average band of 3 to 7.

    Piotroski F-Score5 of 9
    Piotroski StrengthAverage

    Income Statement

    FFO per share was $0.52 for 2025, the latest reported year. Revenue of $1.48B over the last 12 months is down 3.82% from the 12 months before.

    FFO Per Share (2025)$0.52
    Revenue$1.48B
    Revenue Growth (YoY)-3.82%
    Gross Profit$1.48B
    Operating Income-$33.95M
    Pretax Income-$180.75M
    Net Income-$152.14M
    EBITDA$246.29M
    EBIT-$22.92M

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 36.52% of the $4.19B in total assets.

    Cash and Equivalents$110.66M
    Total Debt$2.40B
    Net Debt$2.29B
    Net Debt Per Share$9.52
    Working Capital$130.62M
    Shareholder Equity$1.53B
    Book Value Per Share$6.35
    Tangible Book Value$1.51B
    Tangible Book Per Share$6.28
    Total Assets$4.19B
    Total Liabilities$2.66B

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $118.66M of capital spending, operating cash flow left -$64.65M of free cash flow.

    Operating Cash Flow$54.01M
    Capital Expenditures$118.66M
    Free Cash Flow-$64.65M
    FCF Per Share-$0.27
    Depreciation and Amortization$269.21M
    Dividends Paid$9.68M
    Share Repurchases$2.78M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -2.30%, against a 5-year average of -7.63%.

    Gross Margin100.00%
    Operating Margin-2.30%
    Pretax Margin-12.22%
    Net Margin-10.29%
    EBITDA Margin16.65%
    EBIT Margin-1.55%
    FCF Margin-4.37%
    Operating Margin (5Y Average)-7.63%
    Net Margin (5Y Average)-10.48%

    Growth

    Revenue grew 6.21% a year over 3 years.

    Revenue Growth (3Y CAGR)+6.21%
    Revenue Growth (5Y CAGR)-1.18%
    Book Value Per Share Growth (2Y CAGR)-15.77%
    Tangible Book Per Share Growth (2Y CAGR)-15.68%

    Revenue and profit by year

    Dividends and Yields

    DHC pays out 7.69% of 2025 FFO as dividends.

    Dividend Per Share (Annual)$0.04
    Dividend Yield0.56%
    Payment ScheduleQuarterly
    Dividend Growth (3Y CAGR)0.00%
    Dividend Growth (5Y CAGR)+5.92%
    Payout Ratio (2025 FFO)7.69%
    FFO Yield (2025)7.26%
    FCF Yield-3.75%
    Buyback Yield0.16%
    Shareholder Yield0.72%

    Full dividend history

    Peer Position

    Against 11 similar companies, DHC has the 9th highest P/FFO and the 10th highest P/S.

    P/FFO10.4x vs 11.3x median
    P/S Ratio1.2x vs 5.3x median
    ROIC-0.58% vs 4.21% median
    Revenue Growth (Trailing 4 Quarters, YoY)-3.82% vs +19.51% median
    Dividend Yield0.56% vs 5.93% median

    Competitors compared

    Analyst Forecast

    FFO per share estimates imply 30.09% growth a year over the next 2 years. Consensus estimates put revenue growth at 0.29% a year over the next 2 fiscal years.

    FFO Per Share Growth Forecast (2Y CAGR)+30.09%
    Revenue Growth Forecast (2Y CAGR)+0.29%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewOvervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About DHC

    What is DHC's market cap?

    Diversified Healthcare Trust has a market cap of $1.72B. Its enterprise value, which adds debt and subtracts cash, is $4.02B.

    What is DHC's price to FFO ratio?

    Diversified Healthcare Trust has a P/FFO of 10.4x on its 2026 FFO estimate.

    How many shares of DHC are outstanding?

    Diversified Healthcare Trust has 240.98M shares outstanding. The count is up 0.25% from a year earlier.

    Does DHC pay a dividend?

    Yes. Diversified Healthcare Trust pays $0.04 a share a year, a dividend yield of 0.56%.

    How much debt does DHC have?

    Diversified Healthcare Trust has $2.40B of total debt and $110.66M of cash and equivalents, a net debt position of $2.29B.